APA
Bristoyiannis G., Germanos N., Grekas D., Hatzidimitriou C., Iatrou C., Memmos D., Moutafis S., Papachristoforou K., Papadoniou A., Pappas M., Sakellariou G. A., Siamopoulos K. C., Sombolos K., Stamatelou K., Stathakis C. P., Stavgiannoudakis G., Stratigis S., Syrganis C., Tsakiris D., Valis D., Vlahojannis J. G. & Vlassopoulos D. (20140327). Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients. : Current therapeutic research, clinical and experimental.
Chicago
Bristoyiannis Georgios, Germanos Nikolaos, Grekas Dimitrios, Hatzidimitriou Christos, Iatrou Christos, Memmos Dimitrios, Moutafis Spiros, Papachristoforou Konstantinos, Papadoniou Antonis, Pappas Michalis, Sakellariou George A, Siamopoulos Kostas C, Sombolos Konstantinos, Stamatelou Kiriaki, Stathakis Charalambos P, Stavgiannoudakis Georgios, Stratigis Spiros, Syrganis Christos, Tsakiris Dimitris, Valis Dimitris, Vlahojannis Jannis G and Vlassopoulos Dimosthenis. 20140327. Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients. : Current therapeutic research, clinical and experimental.
Harvard
Bristoyiannis G., Germanos N., Grekas D., Hatzidimitriou C., Iatrou C., Memmos D., Moutafis S., Papachristoforou K., Papadoniou A., Pappas M., Sakellariou G. A., Siamopoulos K. C., Sombolos K., Stamatelou K., Stathakis C. P., Stavgiannoudakis G., Stratigis S., Syrganis C., Tsakiris D., Valis D., Vlahojannis J. G. and Vlassopoulos D. (20140327). Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients. : Current therapeutic research, clinical and experimental.
MLA
Bristoyiannis Georgios, Germanos Nikolaos, Grekas Dimitrios, Hatzidimitriou Christos, Iatrou Christos, Memmos Dimitrios, Moutafis Spiros, Papachristoforou Konstantinos, Papadoniou Antonis, Pappas Michalis, Sakellariou George A, Siamopoulos Kostas C, Sombolos Konstantinos, Stamatelou Kiriaki, Stathakis Charalambos P, Stavgiannoudakis Georgios, Stratigis Spiros, Syrganis Christos, Tsakiris Dimitris, Valis Dimitris, Vlahojannis Jannis G and Vlassopoulos Dimosthenis. Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients. : Current therapeutic research, clinical and experimental. 20140327.